10.11.2023 • News

Azelis to Acquire Agrochemicals Distributor Agspec Australia

Azelis has agreed to acquire 100% of the shares of Agspec Australia, a leading distributor of crop nutrition, crop protection and specialty agricultural products in Australia. Financial terms of the transaction, which is expected to close in the first quarter of 2024 and is subject to customary closing conditions, were not disclosed.

The acquisition, Belgium-headquartered Azelis said, enables it to offer a wider and more diversified range of products and services to its customers in the agricultural and horticultural markets as Agspec's core business is dedicated to formulating and delivering solutions to its customers.

Established in 2004, Agspec is headquartered in Mount Gambier, South Australia, with sales representatives covering Western Australia, South Australia, Victoria, and Queensland. The company is co-managed by two founders, Jonathon Lillecrapp and Andrew Glynn, who will remain with the company.

Lillecrapp and Glynn commented: “We are delighted to be joining Azelis, with their expertise in developing and marketing specialty chemicals, as this is synonymous with the Agspec business model. Azelis provides the critical mass for Agspec to fully realize its potential. Innovation being at the heart of Azelis' strategy, it seemed obvious to us that they would be the best and most complementary partner.”

Sertaç Sürür, CEO and president of Azelis APAC, added: “This acquisition strengthens our lateral value chain for the broadacre and horticultural markets, enabling us to offer a truly compelling proposition for both principals and customers. Agspec’s portfolio is highly complementary to our current one and will enhance the life sciences range of Azelis Australia.”

© Shutterstock
© Shutterstock

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read